Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: A Series of 308 Cases

Apar Kishor Ganti, Anil Potti, Michael Koch, Ketki Tendulkar, David Hanekom, Vijay Koka, Ralph Levitt

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Pancreatic cancer is the fourth leading cause of cancer death in both men and women with a mortality: incidence ratio of 0.99. In an effort to describe the role of clinical features at initial presentation, we conducted a retrospective observational study in patients with a biopsy-proven diagnosis of adenocarcinoma of the pancreas. Between 1986 and 2001, 308 patients (160 males, 148 females) were diagnosed with pancreatic adenocarcinoma. The mean age at diagnosis was 70.1 yr (range: 34-96 yr). The mean survival was 7.6 mo (range: 0-97 mo). Statistical analysis was performed using log-rank tests and analysis of variance. As expected, age at diagnosis was a significant factor affecting survival, with older patients doing relatively poorly (p < 0.05). Patients with a good performance status performed significantly better than those with a poor performance status (p < 0.01). In addition, the presence of the tumor in the head of the pancreas was a predictor for improved survival (p < 0.01). Although smoking increased the chances of detection at an earlier age, neither diabetes mellitus nor a positive smoking history had a statistically significant effect on the survival. Pancreatic adenocarcinoma is a disease of the elderly associated with a poorer outcome. Knowledge of possible clinical predictors of survival may lead to better patient counseling regarding prognosis.

Original languageEnglish (US)
Pages (from-to)233-237
Number of pages5
JournalMedical Oncology
Volume19
Issue number4
DOIs
StatePublished - Dec 1 2002

Fingerprint

Adenocarcinoma
Survival
Pancreas
Smoking
Pancreatic Neoplasms
Observational Studies
Counseling
Cause of Death
Neoplasms
Diabetes Mellitus
Analysis of Variance
Retrospective Studies
History
Biopsy
Mortality
Incidence

Keywords

  • Clinical features
  • Epidemiology
  • Pancreatic adenocarcinoma
  • Risk factors
  • Survival

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma : A Series of 308 Cases. / Ganti, Apar Kishor; Potti, Anil; Koch, Michael; Tendulkar, Ketki; Hanekom, David; Koka, Vijay; Levitt, Ralph.

In: Medical Oncology, Vol. 19, No. 4, 01.12.2002, p. 233-237.

Research output: Contribution to journalArticle

Ganti, Apar Kishor ; Potti, Anil ; Koch, Michael ; Tendulkar, Ketki ; Hanekom, David ; Koka, Vijay ; Levitt, Ralph. / Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma : A Series of 308 Cases. In: Medical Oncology. 2002 ; Vol. 19, No. 4. pp. 233-237.
@article{a16b66466df94de2910410cd724f8c63,
title = "Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: A Series of 308 Cases",
abstract = "Pancreatic cancer is the fourth leading cause of cancer death in both men and women with a mortality: incidence ratio of 0.99. In an effort to describe the role of clinical features at initial presentation, we conducted a retrospective observational study in patients with a biopsy-proven diagnosis of adenocarcinoma of the pancreas. Between 1986 and 2001, 308 patients (160 males, 148 females) were diagnosed with pancreatic adenocarcinoma. The mean age at diagnosis was 70.1 yr (range: 34-96 yr). The mean survival was 7.6 mo (range: 0-97 mo). Statistical analysis was performed using log-rank tests and analysis of variance. As expected, age at diagnosis was a significant factor affecting survival, with older patients doing relatively poorly (p < 0.05). Patients with a good performance status performed significantly better than those with a poor performance status (p < 0.01). In addition, the presence of the tumor in the head of the pancreas was a predictor for improved survival (p < 0.01). Although smoking increased the chances of detection at an earlier age, neither diabetes mellitus nor a positive smoking history had a statistically significant effect on the survival. Pancreatic adenocarcinoma is a disease of the elderly associated with a poorer outcome. Knowledge of possible clinical predictors of survival may lead to better patient counseling regarding prognosis.",
keywords = "Clinical features, Epidemiology, Pancreatic adenocarcinoma, Risk factors, Survival",
author = "Ganti, {Apar Kishor} and Anil Potti and Michael Koch and Ketki Tendulkar and David Hanekom and Vijay Koka and Ralph Levitt",
year = "2002",
month = "12",
day = "1",
doi = "10.1385/MO:19:4:233",
language = "English (US)",
volume = "19",
pages = "233--237",
journal = "Medical Oncology and Tumor Pharmacotherapy",
issn = "1357-0560",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma

T2 - A Series of 308 Cases

AU - Ganti, Apar Kishor

AU - Potti, Anil

AU - Koch, Michael

AU - Tendulkar, Ketki

AU - Hanekom, David

AU - Koka, Vijay

AU - Levitt, Ralph

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Pancreatic cancer is the fourth leading cause of cancer death in both men and women with a mortality: incidence ratio of 0.99. In an effort to describe the role of clinical features at initial presentation, we conducted a retrospective observational study in patients with a biopsy-proven diagnosis of adenocarcinoma of the pancreas. Between 1986 and 2001, 308 patients (160 males, 148 females) were diagnosed with pancreatic adenocarcinoma. The mean age at diagnosis was 70.1 yr (range: 34-96 yr). The mean survival was 7.6 mo (range: 0-97 mo). Statistical analysis was performed using log-rank tests and analysis of variance. As expected, age at diagnosis was a significant factor affecting survival, with older patients doing relatively poorly (p < 0.05). Patients with a good performance status performed significantly better than those with a poor performance status (p < 0.01). In addition, the presence of the tumor in the head of the pancreas was a predictor for improved survival (p < 0.01). Although smoking increased the chances of detection at an earlier age, neither diabetes mellitus nor a positive smoking history had a statistically significant effect on the survival. Pancreatic adenocarcinoma is a disease of the elderly associated with a poorer outcome. Knowledge of possible clinical predictors of survival may lead to better patient counseling regarding prognosis.

AB - Pancreatic cancer is the fourth leading cause of cancer death in both men and women with a mortality: incidence ratio of 0.99. In an effort to describe the role of clinical features at initial presentation, we conducted a retrospective observational study in patients with a biopsy-proven diagnosis of adenocarcinoma of the pancreas. Between 1986 and 2001, 308 patients (160 males, 148 females) were diagnosed with pancreatic adenocarcinoma. The mean age at diagnosis was 70.1 yr (range: 34-96 yr). The mean survival was 7.6 mo (range: 0-97 mo). Statistical analysis was performed using log-rank tests and analysis of variance. As expected, age at diagnosis was a significant factor affecting survival, with older patients doing relatively poorly (p < 0.05). Patients with a good performance status performed significantly better than those with a poor performance status (p < 0.01). In addition, the presence of the tumor in the head of the pancreas was a predictor for improved survival (p < 0.01). Although smoking increased the chances of detection at an earlier age, neither diabetes mellitus nor a positive smoking history had a statistically significant effect on the survival. Pancreatic adenocarcinoma is a disease of the elderly associated with a poorer outcome. Knowledge of possible clinical predictors of survival may lead to better patient counseling regarding prognosis.

KW - Clinical features

KW - Epidemiology

KW - Pancreatic adenocarcinoma

KW - Risk factors

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0036918101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036918101&partnerID=8YFLogxK

U2 - 10.1385/MO:19:4:233

DO - 10.1385/MO:19:4:233

M3 - Article

C2 - 12512917

AN - SCOPUS:0036918101

VL - 19

SP - 233

EP - 237

JO - Medical Oncology and Tumor Pharmacotherapy

JF - Medical Oncology and Tumor Pharmacotherapy

SN - 1357-0560

IS - 4

ER -